PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,666 | -94.3% | 106,743 | -66.7% | 0.00% | -100.0% |
| Q1 2023 | $312,608 | -7.2% | 320,295 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $336,773 | -25.5% | 323,820 | -17.6% | 0.00% | -50.0% |
| Q3 2022 | $452,000 | +56.9% | 392,871 | +155.3% | 0.00% | +100.0% |
| Q2 2022 | $288,000 | -67.5% | 153,891 | -10.2% | 0.00% | -66.7% |
| Q3 2021 | $886,000 | -36.0% | 171,428 | -52.6% | 0.01% | -33.3% |
| Q2 2021 | $1,384,000 | -0.4% | 361,434 | -33.2% | 0.01% | -18.2% |
| Q1 2021 | $1,390,000 | +4.0% | 540,766 | +1.2% | 0.01% | -8.3% |
| Q4 2020 | $1,336,000 | +69.1% | 534,397 | +40.0% | 0.01% | +50.0% |
| Q3 2020 | $790,000 | -14.4% | 381,649 | +28.2% | 0.01% | -20.0% |
| Q2 2020 | $923,000 | +34.4% | 297,716 | -1.2% | 0.01% | +11.1% |
| Q1 2020 | $687,000 | -27.5% | 301,436 | +15.3% | 0.01% | 0.0% |
| Q4 2019 | $947,000 | +122.8% | 261,517 | +110.0% | 0.01% | +80.0% |
| Q3 2019 | $425,000 | -43.9% | 124,517 | -22.8% | 0.01% | -50.0% |
| Q2 2019 | $758,000 | +34.9% | 161,252 | -3.9% | 0.01% | +25.0% |
| Q1 2019 | $562,000 | +161.4% | 167,839 | +294.9% | 0.01% | +166.7% |
| Q2 2018 | $215,000 | +131.2% | 42,501 | +245.5% | 0.00% | +50.0% |
| Q4 2017 | $93,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |